You are here

Article Text

Article menu
Chest clinic
Audit, research and guideline update
Clinical management of older people with non-small cell lung cancer in England
Free
  1. Paul Beckett1,
  2. Matthew Callister2,
  3. Laila J Tata3,
  4. Richard Harrison4,
  5. Michael D Peake5,
  6. Roz Stanley6,
  7. Ian Woolhouse7,
  8. Mark Slade8,
  9. Richard B Hubbard9
  1. 1Burton Hospitals NHS Foundation Trust, Burton-on-Trent, UK
  2. 2Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK
  3. 3Department of Epidemiology, University of Nottingham, Nottingham, UK
  4. 4Department of Respiratory Medicine, North Tees General Hospital, Stockton-on-Tees, UK
  5. 5Department of Respiratory Medicine, Glenfield Hospital, Leicester, UK
  6. 6The Information Centre for Health and Social Care, Leeds, UK
  7. 7Department of Respiratory Medicine, University Hospitals of Birmingham, Birmingham, UK
  8. 8Department of Respiratory Medicine, Papworth Hospital, Cambridge, UK
  9. 9Department of Respiratory Medicine, University of Nottingham, Nottingham, UK
  1. Correspondence to Dr Paul Beckett, Burton Hospitals NHS Foundation Trust, Queens Hospital Belvedere Road, Burton-on-Trent DE13 0RB, UK; emailpaulbeckett{at}gmail.com

Abstract

Data for 25261 patients with non-small cell lung cancer whose details were submitted to the National Lung Cancer Audit in England were analysed to assess the effect of age at diagnosis on their clinical management, after accounting for sex, stage, performance status and comorbidity. Multivariate logistic regression showed the odds of having histocytological confirmation and anticancer treatment decreased progressively with age, and was also lower in women. It is likely that these results have a multifactorial explanation, and further research into the attitudes of patients, carers and healthcare professionals, and clinical trials of treatment in older populations, are necessary.

https://doi.org/10.1136/thoraxjnl-2011-200994

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Supplementary materials

    • Supplementary Data

      This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

      Files in this Data Supplement:

    Footnotes

    • Funding The National Lung Cancer Audit in the UK is commissioned by the Healthcare Quality Improvement Partnership (HQIP) with funds from the Department of Health and maintained jointly by the Health and Social Care Information Centre (HSCIC) and the Royal College of Physicians.

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.